Tokyo Tape
Sign in
← PeptiDream

Annual report

4587.TEDINET S100VITV
Period2024-01-01 → 2024-12-31
Filed2025-03-28
StandardIFRS
ConsolidatedYes
Data checks21 of 22 passed
Key figures · 159
MetricValuePeriodScopeSource row
Revenue¥46.7bn2024-01-01 → 2024-12-31Cons.Revenue IFRS
Revenue¥28.7bn2023-01-01 → 2023-12-31Cons.Revenue IFRS
Revenue¥26.9bn2022-01-01 → 2022-12-31dCons.Net sales (5-year summary)
Revenue¥9.4bn2021-01-01 → 2021-12-31dCons.Revenue IFRS (5-year summary)
Operating income¥21.1bn2024-01-01 → 2024-12-31Cons.Operating profit loss IFRS
Operating income¥6.8bn2023-01-01 → 2023-12-31Cons.Operating profit loss IFRS
Ordinary income¥8.1bn2022-01-01 → 2022-12-31dCons.Ordinary income loss (5-year summary)
Profit before tax¥20.9bn2024-01-01 → 2024-12-31Cons.Profit loss before tax IFRS
Profit before tax¥4.4bn2023-01-01 → 2023-12-31Cons.Profit loss before tax IFRS
Profit before tax¥6.7bn2022-01-01 → 2022-12-31dCons.Profit loss before tax IFRS (5-year summary)
Profit before tax¥3.8bn2021-01-01 → 2021-12-31dCons.Profit loss before tax IFRS (5-year summary)
Net income (owners)¥15.0bn2024-01-01 → 2024-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥3.0bn2023-01-01 → 2023-12-31Cons.Profit loss attributable to owners of parent IFRS
Net income (owners)¥6.6bn2022-01-01 → 2022-12-31dCons.Profit loss attributable to owners of parent (5-year summary)
Net income (owners)¥7.6bn2022-01-01 → 2022-12-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income (owners)¥2.6bn2021-01-01 → 2021-12-31dCons.Profit loss attributable to owners of parent IFRS (5-year summary)
Net income¥15.0bn2024-01-01 → 2024-12-31Cons.Profit loss IFRS
Net income¥3.0bn2023-01-01 → 2023-12-31Cons.Profit loss IFRS
Total assets¥92.8bnat 2024-12-31Cons.Assets IFRS
Total assets¥69.5bnat 2023-12-31Cons.Assets IFRS
Total assets¥60.1bnat 2022-12-31dCons.Total assets (5-year summary)
Total assets¥63.9bnat 2022-12-31dCons.Total assets IFRS (5-year summary)
Total assets¥27.0bnat 2021-12-31dCons.Total assets IFRS (5-year summary)
Total assets¥26.1bnat 2020-12-31dCons.Total assets IFRS (5-year summary)
Total liabilities¥36.0bnat 2024-12-31Cons.Liabilities IFRS
Total liabilities¥29.1bnat 2023-12-31Cons.Liabilities IFRS
Net assets / equity¥56.8bnat 2024-12-31Cons.Equity IFRS
Net assets / equity¥40.3bnat 2023-12-31Cons.Equity IFRS
Net assets / equity¥32.0bnat 2022-12-31dCons.Equity IFRS
Net assets / equity¥30.5bnat 2022-12-31dCons.Net assets (5-year summary)
Equity (owners)¥56.8bnat 2024-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥40.3bnat 2023-12-31Cons.Equity attributable to owners of parent IFRS
Equity (owners)¥32.0bnat 2022-12-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥25.4bnat 2021-12-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Equity (owners)¥21.3bnat 2020-12-31dCons.Equity attributable to owners of parent IFRS (5-year summary)
Cash & equivalents¥48.1bnat 2024-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥19.5bnat 2023-12-31Cons.Cash and cash equivalents IFRS
Cash & equivalents¥5.2bnat 2022-12-31dCons.Cash and cash equivalents IFRS
Cash & equivalents¥11.7bnat 2021-12-31dCons.Cash and cash equivalents IFRS (5-year summary)
Cash & equivalents¥7.1bnat 2020-12-31dCons.Cash and cash equivalents IFRS (5-year summary)
Operating cash flow¥23.8bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow¥12.4bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in operating activities IFRS
Operating cash flow−¥350m2022-01-01 → 2022-12-31dCons.Net cash provided by used in operating activities (5-year summary)
Operating cash flow−¥83m2022-01-01 → 2022-12-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Operating cash flow¥6.7bn2021-01-01 → 2021-12-31dCons.Cash flows from used in operating activities IFRS (5-year summary)
Investing cash flow¥8.4bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow¥1.3bn2023-01-01 → 2023-12-31Cons.Net cash provided by used in investing activities IFRS
Investing cash flow−¥27.3bn2022-01-01 → 2022-12-31dCons.Net cash provided by used in investing activities (5-year summary)
Investing cash flow−¥27.4bn2022-01-01 → 2022-12-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Investing cash flow−¥2.3bn2021-01-01 → 2021-12-31dCons.Cash flows from used in investing activities IFRS (5-year summary)
Financing cash flow−¥3.0bn2024-01-01 → 2024-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥264m2023-01-01 → 2023-12-31Cons.Net cash provided by used in financing activities IFRS
Financing cash flow¥21.0bn2022-01-01 → 2022-12-31dCons.Net cash provided by used in financing activities (5-year summary)
Financing cash flow¥20.8bn2022-01-01 → 2022-12-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
Financing cash flow¥66m2021-01-01 → 2021-12-31dCons.Cash flows from used in financing activities IFRS (5-year summary)
EPS (basic)¥115.852024-01-01 → 2024-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥23.412023-01-01 → 2023-12-31Cons.Basic earnings loss per share IFRS
EPS (basic)¥51.132022-01-01 → 2022-12-31dCons.Basic earnings loss per share (5-year summary)
EPS (basic)¥58.192022-01-01 → 2022-12-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (basic)¥19.962021-01-01 → 2021-12-31dCons.Basic earnings loss per share IFRS (5-year summary)
EPS (diluted)¥115.682024-01-01 → 2024-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥23.382023-01-01 → 2023-12-31Cons.Diluted earnings loss per share IFRS
EPS (diluted)¥58.142022-01-01 → 2022-12-31dCons.Diluted earnings loss per share IFRS (5-year summary)
EPS (diluted)¥19.812021-01-01 → 2021-12-31dCons.Diluted earnings loss per share IFRS (5-year summary)
Net assets per share¥437.63at 2024-12-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥311.16at 2023-12-31Cons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥234.8at 2022-12-31dCons.Net assets per share (5-year summary)
Net assets per share¥246.63at 2022-12-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥195.1at 2021-12-31dCons.Equity to asset ratio IFRS (5-year summary)
Net assets per share¥168.1at 2020-12-31dCons.Equity to asset ratio IFRS (5-year summary)
Equity ratio61.2%at 2024-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio58.1%at 2023-12-31Cons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio50.5%at 2022-12-31dCons.Equity to asset ratio (5-year summary)
Equity ratio50.2%at 2022-12-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio93.8%at 2021-12-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
Equity ratio81.4%at 2020-12-31dCons.Ratio of owners equity to gross assets IFRS (5-year summary)
ROE30.9%2024-01-01 → 2024-12-31Cons.Rate of return on equity IFRS (5-year summary)
ROE8.4%2023-01-01 → 2023-12-31Cons.Rate of return on equity IFRS (5-year summary)
ROE24.4%2022-01-01 → 2022-12-31dCons.Rate of return on equity (5-year summary)
ROE26.3%2022-01-01 → 2022-12-31dCons.Rate of return on equity IFRS (5-year summary)
ROE11.0%2021-01-01 → 2021-12-31dCons.Rate of return on equity IFRS (5-year summary)
Employees621at 2024-12-31Cons.Number of employees
Employees603at 2023-12-31Cons.Number of employees
Employees569at 2022-12-31dCons.Number of employees
Employees141at 2021-12-31dCons.Number of employees
Employees128at 2020-12-31dCons.Number of employees
Revenue¥31.3bn2024-01-01 → 2024-12-31StandaloneNet sales
Revenue¥12.7bn2023-01-01 → 2023-12-31StandaloneNet sales
Revenue¥15.4bn2022-01-01 → 2022-12-31dStandaloneNet sales (5-year summary)
Revenue¥9.4bn2021-01-01 → 2021-12-31dStandaloneNet sales (5-year summary)
Revenue¥11.7bn2020-01-01 → 2020-12-31dStandaloneNet sales (5-year summary)
Operating income¥21.0bn2024-01-01 → 2024-12-31StandaloneOperating income
Operating income¥6.4bn2023-01-01 → 2023-12-31StandaloneOperating income
Ordinary income¥20.5bn2024-01-01 → 2024-12-31StandaloneOrdinary income
Ordinary income¥6.4bn2023-01-01 → 2023-12-31StandaloneOrdinary income
Ordinary income¥8.8bn2022-01-01 → 2022-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥4.8bn2021-01-01 → 2021-12-31dStandaloneOrdinary income loss (5-year summary)
Ordinary income¥7.0bn2020-01-01 → 2020-12-31dStandaloneOrdinary income loss (5-year summary)
Profit before tax¥29.8bn2024-01-01 → 2024-12-31StandaloneIncome before income taxes
Profit before tax¥7.0bn2023-01-01 → 2023-12-31StandaloneIncome before income taxes
Net income¥21.1bn2024-01-01 → 2024-12-31StandaloneProfit loss
Net income¥5.8bn2023-01-01 → 2023-12-31StandaloneProfit loss
Net income¥4.3bn2022-01-01 → 2022-12-31dStandaloneNet income loss (5-year summary)
Net income¥3.6bn2021-01-01 → 2021-12-31dStandaloneNet income loss (5-year summary)
Net income¥4.4bn2020-01-01 → 2020-12-31dStandaloneNet income loss (5-year summary)
Total assets¥89.7bnat 2024-12-31StandaloneAssets
Total assets¥68.2bnat 2023-12-31StandaloneAssets
Total assets¥55.2bnat 2022-12-31dStandaloneTotal assets (5-year summary)
Total assets¥26.6bnat 2021-12-31dStandaloneTotal assets (5-year summary)
Total assets¥26.3bnat 2020-12-31dStandaloneTotal assets (5-year summary)
Total liabilities¥34.1bnat 2024-12-31StandaloneLiabilities
Total liabilities¥27.6bnat 2023-12-31StandaloneLiabilities
Net assets / equity¥55.6bnat 2024-12-31StandaloneNet assets
Net assets / equity¥40.6bnat 2023-12-31StandaloneNet assets
Net assets / equity¥29.4bnat 2022-12-31dStandaloneNet assets
Net assets / equity¥25.0bnat 2021-12-31dStandaloneNet assets (5-year summary)
Net assets / equity¥21.2bnat 2020-12-31dStandaloneNet assets (5-year summary)
Cash and deposits¥44.6bnat 2024-12-31StandaloneCash and deposits
Cash and deposits¥16.2bnat 2023-12-31StandaloneCash and deposits
Cash & equivalents¥11.7bnat 2021-12-31dStandaloneCash and cash equivalents (5-year summary)
Cash & equivalents¥7.1bnat 2020-12-31dStandaloneCash and cash equivalents (5-year summary)
Operating cash flow¥6.7bn2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Operating cash flow¥1.7bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in operating activities (5-year summary)
Investing cash flow−¥2.3bn2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Investing cash flow−¥1.2bn2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in investing activities (5-year summary)
Financing cash flow¥66m2021-01-01 → 2021-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
Financing cash flow−¥237m2020-01-01 → 2020-12-31dStandaloneNet cash provided by used in financing activities (5-year summary)
EPS (basic)¥162.62024-01-01 → 2024-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥44.852023-01-01 → 2023-12-31StandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥33.112022-01-01 → 2022-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥27.982021-01-01 → 2021-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (basic)¥35.42020-01-01 → 2020-12-31dStandaloneBasic earnings loss per share (5-year summary)
EPS (diluted)¥27.782021-01-01 → 2021-12-31dStandaloneDiluted earnings per share (5-year summary)
EPS (diluted)¥34.262020-01-01 → 2020-12-31dStandaloneDiluted earnings per share (5-year summary)
Net assets per share¥428.73at 2024-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥312.89at 2023-12-31StandaloneNet assets per share (5-year summary)
Net assets per share¥226.48at 2022-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥192.39at 2021-12-31dStandaloneNet assets per share (5-year summary)
Net assets per share¥168.1at 2020-12-31dStandaloneNet assets per share (5-year summary)
Equity ratio62.0%at 2024-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio59.5%at 2023-12-31StandaloneEquity to asset ratio (5-year summary)
Equity ratio53.2%at 2022-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio93.8%at 2021-12-31dStandaloneEquity to asset ratio (5-year summary)
Equity ratio80.5%at 2020-12-31dStandaloneEquity to asset ratio (5-year summary)
ROE43.8%2024-01-01 → 2024-12-31StandaloneRate of return on equity (5-year summary)
ROE16.6%2023-01-01 → 2023-12-31StandaloneRate of return on equity (5-year summary)
ROE15.8%2022-01-01 → 2022-12-31dStandaloneRate of return on equity (5-year summary)
ROE15.6%2021-01-01 → 2021-12-31dStandaloneRate of return on equity (5-year summary)
ROE23.4%2020-01-01 → 2020-12-31dStandaloneRate of return on equity (5-year summary)
Shares issued130,010,400at 2024-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued130,010,400at 2023-12-31StandaloneTotal number of issued shares (5-year summary)
Shares issued130,010,400at 2022-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued130,010,400at 2021-12-31dStandaloneTotal number of issued shares (5-year summary)
Shares issued125,910,400at 2020-12-31dStandaloneTotal number of issued shares (5-year summary)
Employees157at 2024-12-31StandaloneNumber of employees
Employees153at 2023-12-31StandaloneNumber of employees
Employees155at 2022-12-31dStandaloneNumber of employees
Employees141at 2021-12-31dStandaloneNumber of employees
Employees128at 2020-12-31dStandaloneNumber of employees

Periods use the dates stated in the filing. d = earlier-year period dated by calendar; v = that date confirmed by the company's own earlier filing.

Segments · 28
SegmentItemPeriodValue
Reconciling Itemsreconcilingrevenue2024-01-01 → 2024-12-31−¥741m
Reconciling Itemsreconcilingrevenue intersegment2024-01-01 → 2024-12-31−¥741m
Drug Discovery And Development Businessreportable segmentemployeesat 2024-12-31157 pure
Drug Discovery And Development Businessreportable segmentrevenue2024-01-01 → 2024-12-31¥31.3bn
Drug Discovery And Development Businessreportable segmentrevenue external2024-01-01 → 2024-12-31¥31.3bn
Drug Discovery And Development Businessreportable segmentsegment profit2024-01-01 → 2024-12-31¥21.0bn
Radiopharmaceuticals Businessreportable segmentemployeesat 2024-12-31464 pure
Radiopharmaceuticals Businessreportable segmentrevenue2024-01-01 → 2024-12-31¥16.1bn
Radiopharmaceuticals Businessreportable segmentrevenue external2024-01-01 → 2024-12-31¥15.4bn
Radiopharmaceuticals Businessreportable segmentrevenue intersegment2024-01-01 → 2024-12-31¥741m
Radiopharmaceuticals Businessreportable segmentsegment profit2024-01-01 → 2024-12-31¥247m
—segment totalrevenue2024-01-01 → 2024-12-31¥47.4bn
—segment totalrevenue external2024-01-01 → 2024-12-31¥46.7bn
—segment totalrevenue intersegment2024-01-01 → 2024-12-31¥741m
—segment totalsegment profit2024-01-01 → 2024-12-31¥21.2bn
Reconciling Itemsreconcilingrevenue2023-01-01 → 2023-12-31−¥87m
Reconciling Itemsreconcilingrevenue intersegment2023-01-01 → 2023-12-31−¥87m
Drug Discovery And Development Businessreportable segmentrevenue2023-01-01 → 2023-12-31¥12.7bn
Drug Discovery And Development Businessreportable segmentrevenue external2023-01-01 → 2023-12-31¥12.7bn
Drug Discovery And Development Businessreportable segmentsegment profit2023-01-01 → 2023-12-31¥6.4bn
Radiopharmaceuticals Businessreportable segmentrevenue2023-01-01 → 2023-12-31¥16.1bn
Radiopharmaceuticals Businessreportable segmentrevenue external2023-01-01 → 2023-12-31¥16.0bn
Radiopharmaceuticals Businessreportable segmentrevenue intersegment2023-01-01 → 2023-12-31¥87m
Radiopharmaceuticals Businessreportable segmentsegment profit2023-01-01 → 2023-12-31¥475m
—segment totalrevenue2023-01-01 → 2023-12-31¥28.8bn
—segment totalrevenue external2023-01-01 → 2023-12-31¥28.7bn
—segment totalrevenue intersegment2023-01-01 → 2023-12-31¥87m
—segment totalsegment profit2023-01-01 → 2023-12-31¥6.9bn

Segment names come from EDINET member IDs; not yet mapped to a common taxonomy.

All source rows · 1,490
ItemContextValueUnit
Cash and depositsPrior1YearInstant_NonConsolidatedMember16163619000JPY
Cash and depositsCurrentYearInstant_NonConsolidatedMember44633739000JPY
Accounts receivable tradePrior1YearInstant_NonConsolidatedMember538582000JPY
Accounts receivable tradeCurrentYearInstant_NonConsolidatedMember915337000JPY
SuppliesPrior1YearInstant_NonConsolidatedMember1392362000JPY
SuppliesCurrentYearInstant_NonConsolidatedMember1415513000JPY
Prepaid expensesPrior1YearInstant_NonConsolidatedMember126772000JPY
Prepaid expensesCurrentYearInstant_NonConsolidatedMember119147000JPY
Other caPrior1YearInstant_NonConsolidatedMember23116000JPY
Other caCurrentYearInstant_NonConsolidatedMember707107000JPY
Current assetsPrior1YearInstant_NonConsolidatedMember18244454000JPY
Current assetsCurrentYearInstant_NonConsolidatedMember47790846000JPY
BuildingsPrior1YearInstant_NonConsolidatedMember4164807000JPY
BuildingsCurrentYearInstant_NonConsolidatedMember4350675000JPY
Accumulated depreciation buildingsPrior1YearInstant_NonConsolidatedMember-1003564000JPY
Accumulated depreciation buildingsCurrentYearInstant_NonConsolidatedMember-1167036000JPY
Buildings netPrior1YearInstant_NonConsolidatedMember3161242000JPY
Buildings netCurrentYearInstant_NonConsolidatedMember3183639000JPY
StructuresPrior1YearInstant_NonConsolidatedMember192138000JPY
StructuresCurrentYearInstant_NonConsolidatedMember192138000JPY
Accumulated depreciation structuresPrior1YearInstant_NonConsolidatedMember-81058000JPY
Accumulated depreciation structuresCurrentYearInstant_NonConsolidatedMember-93599000JPY
Structures netPrior1YearInstant_NonConsolidatedMember111080000JPY
Structures netCurrentYearInstant_NonConsolidatedMember98538000JPY
Tools furniture and fixturesPrior1YearInstant_NonConsolidatedMember4141761000JPY
Tools furniture and fixturesCurrentYearInstant_NonConsolidatedMember4827112000JPY
Accumulated depreciation tools furniture and fixturesPrior1YearInstant_NonConsolidatedMember-2933778000JPY
Accumulated depreciation tools furniture and fixturesCurrentYearInstant_NonConsolidatedMember-3418669000JPY
Tools furniture and fixtures netPrior1YearInstant_NonConsolidatedMember1207982000JPY
Tools furniture and fixtures netCurrentYearInstant_NonConsolidatedMember1408442000JPY
LandPrior1YearInstant_NonConsolidatedMember4104628000JPY
LandCurrentYearInstant_NonConsolidatedMember4104628000JPY
Construction in progressPrior1YearInstant_NonConsolidatedMember261267000JPY
Construction in progressCurrentYearInstant_NonConsolidatedMember7460000JPY
Property plant and equipmentPrior1YearInstant_NonConsolidatedMember8846200000JPY
Property plant and equipmentCurrentYearInstant_NonConsolidatedMember8802709000JPY
SoftwarePrior1YearInstant_NonConsolidatedMember69805000JPY
SoftwareCurrentYearInstant_NonConsolidatedMember72408000JPY
Other iaPrior1YearInstant_NonConsolidatedMember6000000JPY
Other iaCurrentYearInstant_NonConsolidatedMember18978000JPY
Intangible assetsPrior1YearInstant_NonConsolidatedMember75806000JPY
Intangible assetsCurrentYearInstant_NonConsolidatedMember91387000JPY
Investment securitiesPrior1YearInstant_NonConsolidatedMember11402216000JPY
Investment securitiesCurrentYearInstant_NonConsolidatedMember1345662000JPY
Stocks of subsidiaries and affiliatesPrior1YearInstant_NonConsolidatedMember29124954000JPY
Stocks of subsidiaries and affiliatesCurrentYearInstant_NonConsolidatedMember29113989000JPY
Long term loans receivablePrior1YearInstant_NonConsolidatedMember70866000JPY
Long term loans receivableCurrentYearInstant_NonConsolidatedMember64619000JPY
Long term loans receivable from subsidiaries and affiliatesPrior1YearInstant_NonConsolidatedMember414097000JPY
Long term loans receivable from subsidiaries and affiliatesCurrentYearInstant_NonConsolidatedMember－JPY

Every row of the EDINET CSV. Item names are the XBRL element names; filed text is kept in its original Japanese. Filed text is available on Plus and Pro.

Data checks · 21 of 22 passed
balance sheet identityconsolidated 2023-12-31pass rounding
balance sheet identityconsolidated 2024-12-31pass rounding
balance sheet identitynon_consolidated 2023-12-31pass rounding
balance sheet identitynon_consolidated 2024-12-31pass rounding
dei present pass
period resolution pass
statement vs summary · net assetsconsolidated 2022-12-31mismatch
statement vs summary · net assetsnon_consolidated 2022-12-31pass
statement vs summary · net assetsnon_consolidated 2023-12-31pass
statement vs summary · net assetsnon_consolidated 2024-12-31pass
statement vs summary · net income attributable to parentconsolidated 2023-01-01/2023-12-31pass
statement vs summary · net income attributable to parentconsolidated 2024-01-01/2024-12-31pass
statement vs summary · operating cash flowconsolidated 2023-01-01/2023-12-31pass
statement vs summary · operating cash flowconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenueconsolidated 2023-01-01/2023-12-31pass
statement vs summary · revenueconsolidated 2024-01-01/2024-12-31pass
statement vs summary · revenuenon_consolidated 2023-01-01/2023-12-31pass
statement vs summary · revenuenon_consolidated 2024-01-01/2024-12-31pass
statement vs summary · total assetsconsolidated 2023-12-31pass
statement vs summary · total assetsconsolidated 2024-12-31pass
statement vs summary · total assetsnon_consolidated 2023-12-31pass
statement vs summary · total assetsnon_consolidated 2024-12-31pass